%0 Journal Article
%T The Mifepristone Case and the Legitimacy of the FDA.
%A Gluck AR
%J JAMA
%V 329
%N 24
%D 2023 06 27
%M 37266955
%F 157.335
%R 10.1001/jama.2023.8712
%X This Viewpoint discusses a recent federal court decision that invaliated the Food and Drug Administration’s (FDA) approval of mifepristone, a drug used to end pregnancies and manage miscarriage when used with misoprostol, and how that decision challenges the legitimacy and independence of the FDA.